In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response

• Floriane C. M. Braun,

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯
• Jens van den Brandt,

  Affiliation Central Core & Research Facility of Laboratory Animals, University of Greifswald, Greifswald, Germany

  ⨯
• Sören Thomas,

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯
• Sandra Lange,

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯
• Juliane Schrank,

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯
• Claudia Gand,

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯
• Grzegorz K. Przybylski,

  Affiliations Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland

  ⨯
• Katrin Schmoeckel,

  Affiliation Institute of Immunology and Transfusion Medicine, University of Greifswald, Greifswald, Germany

  ⨯
• Barbara M. Bröker,

  Affiliation Institute of Immunology and Transfusion Medicine, University of Greifswald, Greifswald, Germany

  ⨯
• Christian A. Schmidt,

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯
• Piotr Grabarczyk

  * E-mail: pgrabarczyk@yahoo.com

  Affiliation Clinic of Internal Medicine C, Department of Molecular Hematology, University Medicine Greifswald, Greifswald, Germany

  ⨯